| | | | | | | | | | |
|
|
|
|
| Dockets Entered
On October 22, 2007
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1978N-0038
|
| Sunscreen Drug Products
|
|
|
|
|
| 1995S-0316
|
| 75-Day Premarket Notifications for New Dietary Ingredients
|
|
|
|
|
| 2006P-0158
|
| Revoke regulations that provided for the inclusion and addition of sucralose as a non-nutritive sweetener in food
|
|
|
|
|
| 2006P-0394
|
| Revise the labeling requirements for eggs sold in the United States
|
|
|
|
|
| 2006P-0415
|
| Petition Seeking Regulation of Cloned Animals
|
|
|
|
|
| 2006P-0508
|
| Make 2 to 5 milligram pills of Naltrexone to have over-the-counter status
|
|
|
|
|
| 2007D-0249
|
| Guidance for Industry: Preparation of IDEs and INDs for Products Intended to Repair or Replace Knee Cartilage
|
|
|
|
|
| 2007D-0388
|
| Guidance for Industry: Questions and Answers Regarding Adverse Event Reporting and Recordkeeping for Dietary Supplements as Required by the Dietary Supplement and Nonprescription Drug Consumer Protec
|
|
|
|
|
|
|
|
|
| 2007N-0321
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Evaluation of the Impact of Distraction on Consumer Understanding of Risk and Benefit Information in Direct
|
|
|
|
|
|
| 2007N-0347
|
| Information Technology Strategic Planning; Public Meeting
|
|
|
|
|
| 2007N-0356
|
| BEHIND THE COUNTER AVAILABILITY OF CERTAIN DRUGS; Public Meeting
|
|
|
|
|
| 2007N-0357
|
| Medical Device User Fee and Modernization Act; Notice to Public of Web Location of 2008 Proposed Guidance Development; Establishment of a Public Docket.
|
|
|
|
|
| 2007P-0074
|
| Over-the-Counter (OTC) Cough and Cold Drug Products for Children Under 6 Years of Age
|
|
|
|
|
| 2007P-0085
|
| Adopt Regulations of General Applicability to all Food Standards that would Permit Deviations from the Requirements of the Individual Food Standards of Identity
|
|
|
|
|
| 2007P-0158
|
| Patent Listing and Market Exclusivity for Combination Drugs When One Component is a pre-1997 Antibiotic Ingredient
|
|
|
|
|
| 2007P-0210
|
| Reclassification Petition for Human Papillomavirus (HPV) DNA Nested Polymerase Chain Reaction (PCR) Detection under Section 513(f), 21 CFR 860 Subpart C
|
|
|
|
|
| 2007P-0235
|
| Change the labeling requirements for eggs sold in the United States
|
|
|
|
|
| 2007P-0320
|
| Regulation or Guideline to Label Medical Devices that Leach DEHP Plasticizers
|
|
|
|
|
| 2007P-0404
|
| Declare that Cefixime for Oral Suspension, 100 mg/mL, is suitable for submission as an ANDA
|
|
|
|
|
| 2007P-0405
|
| Stay the effective date of any possible refusal of entry AQZ-0251621-2
|
|
| |
|
| 1978N-0038
|
| Sunscreen Drug Products
|
|
|
|
|
| EC 2461
|
| Mr. Todd Miller
|
| Vol #:
|
| 161
|
|
|
|
|
| EC 2462
|
| University of California, Berkeley School of Law
|
| Vol #:
|
| 161
|
|
|
|
|
| EREG 5
|
| J. Kidd
|
| Vol #:
|
| 162
|
|
|
|
|
| EREG 6
|
| C. McDermott
|
| Vol #:
|
| 162
|
|
|
|
|
| 1995S-0316
|
| 75-Day Premarket Notifications for New Dietary Ingredients
|
|
|
|
|
| RPT 413
|
| KSB Group Corp
|
| Vol #:
|
| 325
|
|
|
|
|
| RPT 414
|
| Gold Leaf Sustainable
|
| Vol #:
|
| 325
|
|
|
|
|
| RPT 415
|
| Marlyn Nautriceuticals, LLC
|
| Vol #:
|
| 328
|
|
| |
|
| 2006P-0158
|
| Revoke regulations that provided for the inclusion and addition of sucralose as a non-nutritive sweetener in food
|
|
|
|
|
| C 1
|
| Deb Shore
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006P-0394
|
| Revise the labeling requirements for eggs sold in the United States
|
|
| | | | | | | | |
|
| |
|
| C 433
|
| W. Wilson
|
| Vol #:
|
| 12
|
|
|
|
|
| C 434
|
| E. Schoefer
|
| Vol #:
|
| 12
|
|
| |
|
| 2006P-0415
|
| Petition Seeking Regulation of Cloned Animals
|
|
|
|
|
| C 60
|
| Merrill Kramer
|
| Vol #:
|
| 6
|
|
|
|
|
| 2006P-0508
|
| Make 2 to 5 milligram pills of Naltrexone to have over-the-counter status
|
|
|
|
|
| PDN 1
|
| Janet Woodcock
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007D-0249
|
| Guidance for Industry: Preparation of IDEs and INDs for Products Intended to Repair or Replace Knee Cartilage
|
|
|
|
|
| C 5
|
| Pfizer
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007D-0388
|
| Guidance for Industry: Questions and Answers Regarding Adverse Event Reporting and Recordkeeping for Dietary Supplements as Required by the Dietary Supplement and Nonprescription Drug Consumer Protec
|
|
|
|
|
|
| |
|
|
|
| EC 1
|
| Childrens National Medical Center
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007N-0321
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Evaluation of the Impact of Distraction on Consumer Understanding of Risk and Benefit Information in Direct
|
|
|
|
|
|
|
|
|
|
|
| EC 16
|
| AstraZeneca LP
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 17
|
| Prescription Access Litigation & 26 others
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 18
|
| sanofi-aventis
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 19
|
| Merck Research Laboratories
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 20
|
| Stanford University
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 21
|
| Ms. Wanda Jones
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 22
|
| American Academy of Pediatrics
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007N-0347
|
| Information Technology Strategic Planning; Public Meeting
|
|
|
|
|
| EC 13
|
| Keane, Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007N-0356
|
| Behind The Counter
Availability of Certain Drugs; Public Meeting
|
|
|
|
|
| EAPE 150
|
| Former FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| EAPE 151
|
| Institute for Public Health and Pharmacy
|
| Vol #:
|
| 1
|
|
|
|
|
| EAPE 152
|
| National Women's Health Network
|
| Vol #:
|
| 1
|
|
|
|
|
| EAPE 153
|
| Johnson & Johnson
|
| Vol #:
|
| 1
|
|
|
|
|
| EAPE 154
|
| Wyeth Pharmaceuticals
|
| Vol #:
|
| 1
|
|
|
|
|
| EAPE 155
|
| Hellebusch Research & Consulting, Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| EAPE 156
|
| Medco
|
| Vol #:
|
| 1
|
|
|
|
|
| EAPE 157
|
| Medco
|
| Vol #:
|
| 1
|
|
|
|
|
| EAPE 158
|
| Johnson & Johnson
|
| Vol #:
|
| 1
|
|
|
|
|
| EAPE 159
|
| Johnson & Johnson
|
| Vol #:
|
| 1
|
|
| | | | | | | | |
|
| |
|
| EAPE 160
|
| Medco
|
| Vol #:
|
| 1
|
|
|
|
|
| EAPE 161
|
| test
|
| Vol #:
|
| 1
|
|
| |
|
| 2007N-0357
|
| Medical Device User Fee and Modernization Act; Notice to Public of Web Location of 2008 Proposed Guidance Development; Establishment of a Public Docket.
|
|
|
|
|
| LET 1
|
| Clinical Trials Group Roche Diagnostics
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007P-0074
|
| Over-the-Counter (OTC) Cough and Cold Drug Products for Children Under 6 Years of Age
|
|
|
|
|
| EC 11
|
| Mr. Darrin McQuay
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 12
|
| Mrs. Leah Shannon
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 13
|
| Ms. Marge Yuenger
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 14
|
| Dr. Jennifer Hamilton
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 15
|
| Mr. Andrew Eckhardt
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 16
|
| Mrs. Deidre Daigle
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007P-0085
|
| Adopt Regulations of General Applicability to all Food Standards that would Permit Deviations from the Requirements of the Individual Food Standards of Identity
|
|
|
|
|
| C 346
|
| G. M. Yaport
|
| Vol #:
|
| 6
|
|
| |
|
| 2007P-0158
|
| Patent Listing and Market Exclusivity for Combination Drugs When One Component is a pre-1997 Antibiotic Ingredient
|
|
|
|
|
| LET 1
|
| Jane A. Axelrad
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007P-0210
|
| Reclassification Petition for Human Papillomavirus (HPV) DNA Nested Polymerase Chain Reaction (PCR) Detection under Section 513(f), 21 CFR 860 Subpart C
|
|
|
|
|
| LET 1
|
| HiFi DNA
|
| Vol #:
|
| 5
|
|
|
|
|
| 2007P-0235
|
| Change the labeling requirements for eggs sold in the United States
|
|
|
|
|
| C 153
|
| J. Steinberg
|
| Vol #:
|
| 2
|
|
|
|
|
| C 154
|
| J. Robbins
|
| Vol #:
|
| 2
|
|
|
|
|
| C 155
|
| S. Vania
|
| Vol #:
|
| 2
|
|
|
|
|
| C 156
|
| M. Roy
|
| Vol #:
|
| 2
|
|
|
|
|
| C 157
|
| E. Norton
|
| Vol #:
|
| 2
|
|
|
|
|
| C 158
|
| F. Odabers-Geldiay
|
| Vol #:
|
| 2
|
|
|
|
|
| C 159
|
| F. Smith
|
| Vol #:
|
| 2
|
|
|
|
|
| C 160
|
| R. Thompson
|
| Vol #:
|
| 2
|
|
|
|
|
| C 161
|
| M. Carpenter
|
| Vol #:
|
| 2
|
|
|
|
|
| C 162
|
| Unknown
|
| Vol #:
|
| 2
|
|
|
|
|
| C 163
|
| K. Sadeem
|
| Vol #:
|
| 2
|
|
|
|
|
| C 164
|
| C. Oleva
|
| Vol #:
|
| 2
|
|
|
|
|
| C 165
|
| R. Keirn
|
| Vol #:
|
| 2
|
|
|
|
|
| C 166
|
| D. Malore
|
| Vol #:
|
| 2
|
|
|
|
|
| C 167
|
| P. Fredericks
|
| Vol #:
|
| 2
|
|
